Tim Sauer

3.0k total citations
50 papers, 1.1k citations indexed

About

Tim Sauer is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Tim Sauer has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 20 papers in Hematology and 17 papers in Immunology. Recurrent topics in Tim Sauer's work include CAR-T cell therapy research (28 papers), Acute Myeloid Leukemia Research (14 papers) and Immune Cell Function and Interaction (12 papers). Tim Sauer is often cited by papers focused on CAR-T cell therapy research (28 papers), Acute Myeloid Leukemia Research (14 papers) and Immune Cell Function and Interaction (12 papers). Tim Sauer collaborates with scholars based in Germany, United States and China. Tim Sauer's co-authors include Carsten Müller‐Tidow, Cliona M. Rooney, Bilal Omer, Stephen Gottschalk, Kathan Parikh, Michael Schmitt, Haruko Tashiro, Malcolm K. Brenner, Thomas Shum and Christoph Schliemann and has published in prestigious journals such as Blood, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Tim Sauer

47 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tim Sauer Germany	17	734	378	326	251	237	50	1.1k
Sanfang Tu China	16	582 0.8×	297 0.8×	201 0.6×	154 0.6×	166 0.7×	52	858
Takahiro Kamiya Japan	15	793 1.1×	230 0.6×	648 2.0×	154 0.6×	130 0.5×	40	1.2k
Tatsunori Goto Japan	14	435 0.6×	216 0.6×	240 0.7×	146 0.6×	152 0.6×	48	723
Kai Rejeski Germany	19	753 1.0×	279 0.7×	137 0.4×	160 0.6×	156 0.7×	64	947
Hai Cheng China	18	485 0.7×	345 0.9×	268 0.8×	159 0.6×	361 1.5×	88	1.2k
Stephanie Mgebroff United States	12	1.4k 1.8×	380 1.0×	698 2.1×	359 1.4×	132 0.6×	24	1.7k
Brandon Ballard United States	10	847 1.2×	326 0.9×	311 1.0×	259 1.0×	105 0.4×	16	1.0k
Rayne H. Rouce United States	17	1.6k 2.1×	554 1.5×	924 2.8×	488 1.9×	206 0.9×	54	2.0k
Sunil S. Raikar United States	13	405 0.6×	205 0.5×	252 0.8×	111 0.4×	108 0.5×	37	639
Merav Bar United States	20	893 1.2×	606 1.6×	361 1.1×	303 1.2×	442 1.9×	50	1.8k

Countries citing papers authored by Tim Sauer

Since Specialization

Citations

This map shows the geographic impact of Tim Sauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Sauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Sauer more than expected).

Fields of papers citing papers by Tim Sauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Sauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Sauer. The network helps show where Tim Sauer may publish in the future.

Co-authorship network of co-authors of Tim Sauer

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Sauer. A scholar is included among the top collaborators of Tim Sauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Sauer. Tim Sauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Renders, Simon, Alexander Waclawiczek, Ricarda Schwab, et al.. (2025). Prospective clinical validation of MAC-scoring as an affordable, real-time biomarker for HMA/venetoclax response in AML. Blood. 146(Supplement 1). 3493–3493.

Dysthe, Matthew, et al.. (2025). TIGIT Affects CAR NK-cell Effector Function in the Solid Tumor Microenvironment by Modulating Immune Synapse Strength. Cancer Immunology Research. 13(10). 1576–1590.

Stasik, Sebastian, Jan‐Niklas Eckardt, Christoph Röllig, et al.. (2025). The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML. British Journal of Haematology. 206(5). 1373–1379.

Chen, Qian, et al.. (2024). Structurally Optimized, IL-2-Armored CLL1 CAR-NK Cells Are Highly Potent Effectors Against AML without Hpsc Toxicity. Blood. 144(Supplement 1). 3440–3440. 3 indexed citations

Sharma, Sandhya, et al.. (2024). Cotargeting EBV lytic as well as latent cycle antigens increases T-cell potency against lymphoma. Blood Advances. 8(13). 3360–3371. 2 indexed citations

Wang, Xizhe, Michael Hundemer, Yi Liu, et al.. (2024). The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature. Blood. 143(13). 1269–1281. 16 indexed citations

Schlenk, Richard F., Jan Moritz Middeke, Stefan W. Krause, et al.. (2024). Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML. Blood Advances. 9(2). 375–385. 1 indexed citations

Wang, Lei, Brigitte Neuber, Angela Hückelhoven‐Krauss, et al.. (2024). Extracorporeal photopheresis as a promising strategy for the treatment of graft-versus-host disease after CAR T-cell therapy. Blood Advances. 8(11). 2675–2690. 3 indexed citations

Chen, Qian, Yao Hao, Brigitte Neuber, et al.. (2024). Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia. Journal of Hematology & Oncology. 17(1). 85–85. 9 indexed citations

10.

Schmidt, Christina, Christian Rohde, Cornelius Pauli, et al.. (2023). The ribosomal protein S6 kinase alpha-1 (RPS6KA1) induces resistance to venetoclax/azacitidine in acute myeloid leukemia. Leukemia. 37(8). 1611–1625. 14 indexed citations

11.

Sharma, Sandhya, Mae Woods, Tim Sauer, et al.. (2023). Naive T cells inhibit the outgrowth of intractable antigen-activated memory T cells: implications for T-cell immunotherapy. Journal for ImmunoTherapy of Cancer. 11(4). e006267–e006267. 8 indexed citations

12.

Sharma, Sandhya, Tim Sauer, Bilal Omer, et al.. (2023). Constitutive Interleukin-7 Cytokine Signaling Enhances the Persistence of Epstein–Barr Virus-Specific T-Cells. International Journal of Molecular Sciences. 24(21). 15806–15806. 4 indexed citations

13.

Sauer, Tim, Kathan Parikh, Sandhya Sharma, et al.. (2021). CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity. Blood. 138(4). 318–330. 142 indexed citations

14.

Rahm, Ann‐Kathrin, Maximilian Töllner, Katrin Klein, et al.. (2021). Effects of realistic e-learning cases on students’ learning motivation during COVID-19. PLoS ONE. 16(4). e0249425–e0249425. 40 indexed citations

15.

Ni, Ming, Lei Wang, Wenjie Gong, et al.. (2021). Response to extracorporeal photopheresis therapy of patients with steroid-refractory/-resistant GvHD is associated with up-regulation of Th22 cells and Tfh cells. Cytotherapy. 24(3). 311–319. 9 indexed citations

16.

Yang, Mingya, Lei Wang, Ming Ni, et al.. (2020). Pre-sensitization of Malignant B Cells Through Venetoclax Significantly Improves the Cytotoxic Efficacy of CD19.CAR-T Cells. Frontiers in Immunology. 11. 608167–608167. 32 indexed citations

17.

Shum, Thomas, Bilal Omer, Haruko Tashiro, et al.. (2017). Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells. Cancer Discovery. 7(11). 1238–1247. 220 indexed citations

18.

Inselmann, Sabrina, Tim Sauer, Christoph Schliemann, et al.. (2016). PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation. Bone Marrow Transplantation. 52(2). 317–320. 68 indexed citations

19.

Schmidt, L. H., Dennis Görlich, Tilmann Spieker, et al.. (2014). Prognostic Impact of Bcl-2 Depends on Tumor Histology and Expression of MALAT-1 lncRNA in Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 9(9). 1294–1304. 55 indexed citations

20.

Folwaczny, C, K. Loeschke, Gundula Jäger, et al.. (2000). Endothelial Cell Autoantibodies Are a Marker of Disease Susceptibility in Inflammatory Bowel Disease but Apparently Not Linked to Persistent Measles Virus Infection. Clinical Immunology. 95(3). 197–202. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact